<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-79393</identifier>
<setSpec>0300-8932</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Nuclear magnetic resonance imaging in patients with cardiac pacing devices</dc:title>
<dc:description xml:lang="en">Currently, nuclear magnetic resonance imaging is contraindicated in patients with a pacemaker or implantable cardioverter-defibrillator. This study was carried out because the potential risks in this situation need to be clearly defined. This prospective study evaluated clinical and electrical parameters before and after magnetic resonance imaging was performed in 33 patients (five with implantable cardioverter-defibrillators and 28 with pacemakers). In these patients, magnetic resonance imaging was considered clinically essential. There were no clinical complications. There was a temporary communication failure in two cases, sensing errors during imaging in two cases, and a safety signal was generated in one pacemaker at the maximum magnetic resonance frequency and output level. There were no technical restrictions on imaging nor were there any permanent changes in the performance of the cardiac pacing device (AU)</dc:description>
<dc:creator>Buendía, Francisco</dc:creator>
<dc:creator>Sancho-Tello, María J</dc:creator>
<dc:creator>Sánchez-Gómez, Juan M</dc:creator>
<dc:creator>Arnau, Miguel A</dc:creator>
<dc:creator>Osca, Joaquín</dc:creator>
<dc:creator>Olagüe, José</dc:creator>
<dc:creator>Cano, Óscar</dc:creator>
<dc:creator>Igual, Begoña</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La resonancia magnética está actualmente contraindicada a los pacientes portadores de dispositivos de estimulación cardiaca. Ante la necesidad de concretar los riesgos potenciales derivados de esta situación, surgió este estudio. De forma prospectiva, se evaluaron parámetros clínicos, eléctricos y técnicos antes y después de la realización de la prueba en 33 pacientes (5 desfibriladores automáticos implantables, 28 marcapasos), en los que se consideró clínicamente indispensable realizarla. No se apreciaron complicaciones clínicas. Se detectaron dos casos de fallo temporal de telemetría, dos errores de detección durante la exploración y una respuesta de seguridad en un marcapasos a frecuencia magnética y salida máxima. No hubo limitaciones técnicas en la adquisición de imágenes ni alteraciones permanentes del funcionamiento de los dispositivos de estimulación cardiaca (AU)</dc:description>
<dc:source>Rev Esp Cardiol;63(6): 735-739, jun. 2010. tab, ilus</dc:source>
<dc:identifier>ibc-79393</dc:identifier>
<dc:title xml:lang="es">Resonancia magnética nuclear en pacientes portadores de dispositivos de estimulación cardiaca</dc:title>
<dc:subject>^d28848^s22016</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d2348^s22066</dc:subject>
<dc:subject>^d2348^s22045</dc:subject>
<dc:subject>^d^s22074</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28608^s22074</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d22935^s22045</dc:subject>
<dc:subject>^d30763^s22074</dc:subject>
<dc:subject>^d21027^s22066</dc:subject>
<dc:subject>^d14064^s22045</dc:subject>
<dc:subject>^d23405^s22045</dc:subject>
<dc:subject>^d10326^s22074</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d38829^s22074</dc:subject>
<dc:type>article</dc:type>
<dc:date>201006</dc:date>
</metadata>
</record>
</ibecs-document>
